home / stock / cala / cala news

CALA News and Press, Calithera Biosciences Inc. From 11/25/20

Stock Information
Company Name: Calithera Biosciences Inc.
Stock Symbol: CALA
Market: OTC
Website: calithera.com
Menu
CALA CALA Quote CALA Short CALA News CALA Articles CALA Message Board
Get CALA Alerts

News, Short Squeeze, Breakout and More Instantly...
CALA - Calithera Biosciences Poised For Long-Term Success

Calithera has an important near-term catalyst that could launch the company into a significant commercialization opportunity by mid-year 2021. The company also is running a triplet therapy trial that if successful, would be the only treatment in a $10B market. Calithera is a high-...
CALA - Calithera to Participate in Jefferies Virtual Healthcare Conference and SVB Leerink Oncology 1x1 Day

SOUTH SAN FRANCISCO, Calif., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, today announced...

CALA - Calithera Biosciences Presents New Preclinical Data for CB-668 at Society for Immunotherapy of Cancer (SITC) 2020 Annual Meeting

SOUTH SAN FRANCISCO, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, announced that ...

CALA - Calithera Biosciences' (CALA) CEO Susan Molineaux on Q3 2020 Results - Earnings Call Transcript

Calithera Biosciences, Inc. (CALA) Q3 2020 Earnings Conference Call November 5, 2020 5:00 PM ET Company Participants Jennifer McNealey – Investor Relations Susan Molineaux – Founder, President and Chief Executive Officer Keith Orford – Chief Medical Officer Stephanie Wong...
CALA - Calithera Biosciences Inc (CALA) Q3 2020 Earnings Call Transcript

Image source: The Motley Fool. Calithera Biosciences Inc (NASDAQ: CALA) Q3 2020 Earnings Call Nov 5, 2020 , 5:00 p.m. ET Operator Continue reading For further details see: Calithera Biosciences Inc (CALA) Q3 2020 Earnings Call Transcript ...

CALA - Calithera Biosciences EPS misses by $0.01

Calithera Biosciences (CALA): Q3 GAAP EPS of -$0.32 misses by $0.01.Cash, cash equivalents and investments of $137.7M.Press Release For further details see: Calithera Biosciences EPS misses by $0.01

CALA - Calithera Biosciences Reports Third Quarter 2020 Financial Results and Recent Highlights

--Calithera to Provide Corporate Update via Conference Call and Webcast at 2:00 p.m. PT on November 5, 2020-- SOUTH SAN FRANCISCO, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and de...
CALA - Calithera Biosciences Announces Expansion of Ongoing Clinical Trial Evaluating Telaglenastat in Combination with palbociclib (IBRANCE®)

SOUTH SAN FRANCISCO, Calif., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small-molecule drugs for the treatment of cancer and other life-threatening diseases, today announced...

CALA - Calithera Biosciences Awarded up to $2.4M from Cystic Fibrosis Foundation to Support Clinical Development of Arginase Inhibitor, CB-280

SOUTH SAN FRANCISCO, Calif., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small-molecule drugs for the treatment of cancer and other life-threatening diseases, has been awarde...

CALA - Calithera Biosciences to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020

SOUTH SAN FRANCISCO, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, today anno...
Previous 10 Next 10